Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CRHBP | P24387 | 2/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14680387 | 0.90 | PTPN1 (0.41) | MAPTPABPC1SMN1; SMN2KDM4ECYP1A2 | |
| SCHEMBL22727693 | 0.90 | MAPT (0.40) | MAPTPABPC1SMN1; SMN2KDM4ECYP1A2 | |
| SCHEMBL21889361 | 0.89 | ALDH1A1 (0.44) | MAPTPABPC1SMN1; SMN2KDM4ECYP1A2 | |
| SCHEMBL75348 | 0.83 | CYP1B1 (0.51) | MAPTPABPC1KDM4ECYP1A2LMNA | |
| SCHEMBL22143430 | 0.79 | FGFR1 (0.55) | MAPTSMN1; SMN2KDM4ECRHBPCRHR2 | |
| SCHEMBL10304455 | 0.79 | ALDH1A1 (0.54) | MAPTPABPC1KDM4ECYP1A2HTT | |
| SCHEMBL24334669 | 0.79 | MAPT (0.64) | MAPTPABPC1SMN1; SMN2KDM4ECYP1A2 | |
| SCHEMBL21888318 | 0.79 | CYP1B1 (0.47) | MAPTPABPC1KDM4ECYP1A2LMNA | |
| SCHEMBL75606 | 0.78 | ALDH1A1 (0.56) | MAPTPABPC1SMN1; SMN2KDM4ECRHBP | |
| SCHEMBL29773784 | 0.78 | ALDH1A1 (0.56) | MAPTPABPC1SMN1; SMN2KDM4ECRHBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170133598-A1 | NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE | CANON KK (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170133598-A1 | NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE | CANON KK (JP) | 2017-05-11 | — | — | US | disclosed |
| EP-2788306-B1 | NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE | CANON KK (JP) | 2017-05-03 | — | — | EP | disclosed |
| US-9590199-B2 | Organic compound, organic light emitting device, and image display device | CANON KABUSHIKI KAISHA (JP) | 2017-03-07 | — | — | US | disclosed |
| US-9590199-B2 | Organic compound, organic light emitting device, and image display device | CANON KABUSHIKI KAISHA (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20140374723-A1 | NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20140374723-A1 | NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2014-12-25 | — | — | US | disclosed |
| WO-2013084833-A1 | NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170133598-A1 | NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE | OCIAD1, OCIAD2, OXER1 | MAPT 348/4885PABPC1 3919/4885SMN1; SMN2 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.